April 30, 2018 / 11:08 AM / 7 months ago

BRIEF-Evelo Biosciences Sees IPO Of 5.31 Mln Shares Of Its Common Stock Priced To Be Between $15-$17/ Share

April 30 (Reuters) - Evelo Biosciences Inc:

* EVELO BIOSCIENCES INC SEES IPO OF 5.31 MILLION SHARES OF ITS COMMON STOCK PRICED TO BE BETWEEN $15.00 AND $17.00 PER SHARE - SEC FILING

* EVELO BIOSCIENCES INC - INTENDS TO USE ABOUT $45-$50 MILLION OF IPO PROCEEDS TO FUND PROOF OF CONCEPT CLINICAL TRIALS IN INFLAMMATORY DISEASES PROGRAMS

* EVELO BIOSCIENCES INC - INTENDS TO USE ABOUT $25-$35 MILLION OF IPO PROCEEDS TO FUND PROOF OF CONCEPT CLINICAL TRIALS IN ONCOLOGY PROGRAMS

* EVELO BIOSCIENCES -INTENDS TO USE ABOUT $35-$45 MILLION OF IPO PROCEEDS TO INVEST IN PLATFORM AND TO ADVANCE ADDITIONAL PRECLINICAL DEVELOPMENT ACTIVITIES Source text (bit.ly/2rbI2ON)

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below